Shire PLC (SHP) Rating Reiterated by Citigroup Inc

Shire PLC (SHP) Rating Reiterated by Citigroup Inc


's stock had its "buy" rating reiterated by analysts at Citigroup Inc in a research note issued on Wednesday. They currently have a GBX 6,500 target price on the biopharmaceutical company's stock.



from Biotech News